Diagnostics-maker gets $20M funding boost

05/3/2013 | GenomeWeb Daily News (free registration)

BioFire Diagnostics has received an additional $20 million investment from Athyrium Opportunities Fund, increasing the amount of funding from the group to $45 million. The company said it will use the new funding to further commercialize its FilmArray molecular diagnostic platform. The platform's FilmArray Respiratory Panel can detect 17 viral and three bacterial targets. The company said it is also seeing progress with the product's other panels, including one for sepsis.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN